HealthEquity Q2 revenue $243.5M (+18% YoY), net income $10.6M vs loss, EPS $0.53 non-GAAP

HEALTHEQUITY, INC.

2024-Q2 EPS reported $0.17 revenue$487,981,000

Revenue $243.5M, up 18% YoY from $206.1M; net income $10.6M vs net loss $10.7M in prior year.
Non-GAAP EPS $0.53, up from $0.33; Adjusted EBITDA $88.1M (+31%), margin 36% vs 33%.
HSAs 8.2M (+9% YoY); total HSA assets $23.2B (+13%); HSA cash + investments $23.2B.
FY2024 guidance: revenue $980-990M, non-GAAP EPS $1.97-2.06, Adj. EBITDA $338-348M.
Record HSA asset growth and 360bps adjusted EBITDA margin expansion YoY.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HEALTHEQUITY, INC. reported the second quarter ended July 31, 2023 results: revenue $243.5 million, net income $10.6 million, EPS $0.12 per diluted share.

Period: the second quarter ended July 31, 2023
Revenue: $243.5 million
Net income: $10.6 million
EPS: $0.12 per diluted share
Result: reported results

Exact text from the filing

Reports Second Quarter Ended July 31, 2023 Financial Results Delivers Record HSA Asset Growth, Margin Expansion Highlights of the second quarter include: • Revenue of $243.5 million, an increase of 18% compared to $206.1 million in Q2 FY23. • Net income of $10.6 million, compared to net loss of $10.7 million in Q2 FY23, with non-GAAP net income of $45.6

View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

HEALTHEQUITY, INC. filing history →

Source: SEC EDGAR

accession 0001428336-23-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.